Multiple Sclerosis. Multiple sclerosis (of):generalized
Conditions
Interventions
Intervention 1: The control group: There was no intervention and patients had received the routine treatment. The routine treatment was prescribed due to the doctor's viewpoint and based on disease sy
Treatment - Drugs
The control group: There was no intervention and patients had received the routine treatment. The routine treatment was prescribed due to the doctor's viewpoint and based on disease symptoms and the p
The Case group: In case group, patients in addition to routine therapy were treated with oral Atorvastatin 80 mg daily for one year.
Sponsors
Arak University of Medical Sciences
Eligibility
Sex/Gender
All
Age
1 Years to No maximum
Inclusion criteria
Inclusion criteria: Inclusion criteria: Informed consent for entering the study and Fill out the form informed consent; MS disease Exclusion criteria: Side effects of the drug
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cerebellar function. Timepoint: Pretreatment / six months after treatment / one year after treatment. Method of measurement: Due to physician's viewpoint.;Visual function. Timepoint: Pretreatment / six months after treatment / one year after treatment. Method of measurement: Due to physician's viewpoint.;Sensory function. Timepoint: Pretreatment / six months after treatment / one year after treatment. Method of measurement: Due to physician's viewpoint.;Digestive function - bladder. Timepoint: Pretreatment / six months after treatment / one year after treatment. Method of measurement: Due to physician's viewpoint. | — |
Secondary
| Measure | Time frame |
|---|---|
| Sensitivity to drug. Timepoint: Pretreatment / six months after treatment / one year after treatment. Method of measurement: Due to physician's viewpoint. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Ghasami
Arak University of Medical Sciences Neurology Department
Outcome results
None listed